1. Home
  2. IMRN vs MGRX Comparison

IMRN vs MGRX Comparison

Compare IMRN & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • MGRX
  • Stock Information
  • Founded
  • IMRN 1994
  • MGRX 2021
  • Country
  • IMRN Australia
  • MGRX United States
  • Employees
  • IMRN N/A
  • MGRX N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • MGRX Computer Software: Prepackaged Software
  • Sector
  • IMRN Health Care
  • MGRX Technology
  • Exchange
  • IMRN Nasdaq
  • MGRX Nasdaq
  • Market Cap
  • IMRN 9.2M
  • MGRX 8.1M
  • IPO Year
  • IMRN N/A
  • MGRX 2023
  • Fundamental
  • Price
  • IMRN $1.74
  • MGRX $1.62
  • Analyst Decision
  • IMRN Strong Buy
  • MGRX
  • Analyst Count
  • IMRN 1
  • MGRX 0
  • Target Price
  • IMRN $5.00
  • MGRX N/A
  • AVG Volume (30 Days)
  • IMRN 24.7K
  • MGRX 179.5K
  • Earning Date
  • IMRN 07-07-2025
  • MGRX 08-13-2025
  • Dividend Yield
  • IMRN N/A
  • MGRX N/A
  • EPS Growth
  • IMRN N/A
  • MGRX N/A
  • EPS
  • IMRN N/A
  • MGRX N/A
  • Revenue
  • IMRN $4,048,286.00
  • MGRX $511,084.00
  • Revenue This Year
  • IMRN N/A
  • MGRX N/A
  • Revenue Next Year
  • IMRN N/A
  • MGRX N/A
  • P/E Ratio
  • IMRN N/A
  • MGRX N/A
  • Revenue Growth
  • IMRN 82.90
  • MGRX N/A
  • 52 Week Low
  • IMRN $1.50
  • MGRX $1.32
  • 52 Week High
  • IMRN $2.87
  • MGRX $7.66
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 58.70
  • MGRX 42.14
  • Support Level
  • IMRN $1.68
  • MGRX $1.86
  • Resistance Level
  • IMRN $1.94
  • MGRX $2.04
  • Average True Range (ATR)
  • IMRN 0.09
  • MGRX 0.17
  • MACD
  • IMRN 0.02
  • MGRX -0.03
  • Stochastic Oscillator
  • IMRN 76.92
  • MGRX 0.00

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About MGRX Mangoceuticals Inc.

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

Share on Social Networks: